Abhoy Sarkar's Avatar
published in Blogs
Aug 01, 2022
CME (CME, $199.48) beats Q2 earnings expectations

CME (CME, $199.48) beats Q2 earnings expectations

CME Group posted second quarter earnings of $1.97 per share, exceeding the Zacks Consensus Estimate of $1.92 per share. The figure is higher than the year-ago quarter’s  $1.64 per share.

The company’s revenues came in at $1.24 billion for the quarter, missing the Zacks Consensus Estimate by 0.77%. Revenues were $1.18 billion a year ago.

Following their earnings release, research analysts at Oppenheimer lowered their Q3 2022 earnings estimates for CME Group to $1.92 for the quarter, vs. their previous forecast of $1.95. Oppenheimer has a “Outperform” rating and a $223.00 price target on the shares.

Related Tickers: CME